Shunliang Xu

机构：Emory University, Zunyi Medical University, Second Hospital of Shandong University, Wuhan Union Hospital, Union Hospital, Huazhong University of Science and Technology · ORCID：0000-0001-6516-723X

发表论文 63 篇 · 总被引 1902 次 · h-index 24

代表论文

• Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferroptosis (2022 · Drug Design Development and Therapy · 被引 86)
• Long Non-coding RNAs in Pathogenesis of Neurodegenerative Diseases (2021 · Frontiers in Cell and Developmental Biology · 被引 50)
• 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer’s Disease (2021 · Journal of Alzheimer s Disease · 被引 40)
• Ten-eleven translocation proteins (TETs): tumor suppressors or tumor enhancers? (2021 · Frontiers in Bioscience-Landmark · 被引 27)
• MST1, a novel therapeutic target for Alzheimer's disease, regulates mitochondrial homeostasis by mediating mitochondrial DNA transcription and the PI3K-Akt-ROS pathway (2024 · Journal of Translational Medicine · 被引 25)
• Human Brain Organoid: A Versatile Tool for Modeling Neurodegeneration Diseases and for Drug Screening (2022 · Stem Cells International · 被引 20)